← All tickers

Is ORGO Worth Buying in 2026?

Organogenesis Holdings Inc. Class A Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-05-03

Here’s whether Organogenesis Holdings Inc. Class A Common Stock (ORGO) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: RSI 60 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-9.50% over 10 days); weak 1-year return of -48.2%; 3-month momentum negative (-39.2%). Currently 63.7% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

ORGO is trading below its 200-day MA ($4.12) — a key warning sign the longer-term trend is under pressure. An RSI of 59.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -48.2% compares to +27.9% for SPY (trailed the market by 76.1%). The current 63.7% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $5,181 today
vs. S&P 500 (SPY) — same period trailed market by 76.1%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($4.12)
✗Above 50-day MA ($2.65)
✓RSI(14) neutral zone (30–70) — currently 59.8
✗Positive return (-48.2%)
!Within 10% of period high (−63.7%)
Period Range $2.57
$2.21 $7.08
RSI (14) 59.8
0 · OversoldOverbought · 100

Key Metrics

Price$2.57
Period Return-48.2%
Period High$7.08
Period Low$2.21
Drawdown−63.7%
MA-50$2.65
MA-200$4.12
RSI (14)59.8
Avg Volume (30d)1.8M
vs. SPYtrailed by 77.2%
Return Rank#1076 of 1236

Trade ORGO

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers